Paediatric Cardiology Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Department of Pathology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Eur J Pediatr. 2022 Jan;181(1):287-294. doi: 10.1007/s00431-021-04175-z. Epub 2021 Jul 20.
Acute myocarditis is an inflammatory disease of the myocardium, and it can present as severe heart failure in children. Differential diagnosis with genetic cardiomyopathy can be difficult. The objective of this study is to identify patterns of clinical presentation and to assess invasive and non-invasive measures to differentiate patients with acute myocarditis from patients with dilated genetic cardiomyopathy. We performed a retrospective descriptive study of all paediatric patients (0-16 years old) that presented with new-onset heart failure with left ventricle ejection fraction < 35% in whom we performed an endomyocardial biopsy (EMB) during the period from April 2007 to December 2020. The patients were classified into two groups: Group 1 included 18 patients with myocarditis. Group 2 included 9 patients with genetic cardiomyopathy. Findings favouring a diagnosis of myocarditis included a fulminant or acute presentation (77.8% vs 33.3%, p = 0.01), higher degree of cardiac enzyme elevation (p = 0.011), lower left ventricular dimension z-score (2.2 vs 5.4, p = 0.03) increase of ventricular wall thickness (88.8% vs 33.3%, p = 0.03) and oedema in the EMB. Seven (77.8%) patients with genetic cardiomyopathy had inflammation in the endomyocardial biopsy fulfilling the diagnostic criteria of inflammatory cardiomyopathy.Conclusion: Differentiating patients with a myocarditis from those with genetic cardiomyopathy can be challenging, even performing an EMB. Some patients with genetic cardiomyopathy fulfil the diagnostic criteria of inflammatory cardiomyopathy. Using invasive and non-invasive measures may be useful to develop a predictive model to differentiate myocarditis from genetic cardiomyopathy. What is Known: • Acute myocarditis could present with cardiogenic shock in paediatric patients. • Parvovirus B19 is the main cause of myocarditis in this population. What is New: • Current diagnostic criteria for myocarditis have limited use in paediatric patients presenting with new-onset heart failure. • Some patients with a genetic cardiomyopathy and a new-onset heart failure fulfill the diagnostic criteria of inflammatory cardiomyopathy.
急性心肌炎是一种心肌炎症性疾病,可导致儿童出现严重心力衰竭。与遗传性心肌病的鉴别诊断可能具有挑战性。本研究的目的是确定临床表现模式,并评估侵袭性和非侵袭性措施,以区分急性心肌炎和扩张型遗传性心肌病患者。我们对 2007 年 4 月至 2020 年 12 月期间因新发左心室射血分数<35%心力衰竭而接受心内膜心肌活检(EMB)的所有儿科(0-16 岁)新发心力衰竭患儿进行了回顾性描述性研究。患者分为两组:第 1 组包括 18 例心肌炎患者。第 2 组包括 9 例遗传性心肌病患者。支持心肌炎诊断的发现包括暴发性或急性表现(77.8% vs 33.3%,p=0.01)、更高程度的心脏酶升高(p=0.011)、更低的左心室尺寸 z 评分(2.2 vs 5.4,p=0.03)、心室壁厚度增加(88.8% vs 33.3%,p=0.03)和 EMB 中的水肿。7 例(77.8%)遗传性心肌病患者的 EMB 中有炎症,符合炎症性心肌病的诊断标准。结论:即使进行 EMB,也可能难以区分心肌炎和遗传性心肌病患者。一些遗传性心肌病患者符合炎症性心肌病的诊断标准。使用侵袭性和非侵袭性措施可能有助于建立预测模型,以区分心肌炎和遗传性心肌病。已知:• 急性心肌炎可导致儿科患者出现心源性休克。• 细小病毒 B19 是该人群心肌炎的主要病因。新发现:• 目前的心肌炎诊断标准在新发心力衰竭的儿科患者中应用有限。• 一些新发心力衰竭的遗传性心肌病患者符合炎症性心肌病的诊断标准。